266 related articles for article (PubMed ID: 27865890)
1. Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis.
Gutman J; Kovacs S; Dorsey G; Stergachis A; Ter Kuile FO
Lancet Infect Dis; 2017 Feb; 17(2):184-193. PubMed ID: 27865890
[TBL] [Abstract][Full Text] [Related]
2. A systematic review and meta-analysis of dihydroartemisinin-piperaquine versus sulphadoxine-pyrimethamine for malaria prevention in pregnancy.
Olaleye A; Okusanya BO; Oduwole O; Esu E; Meremikwu M
Int J Gynaecol Obstet; 2019 Jul; 146(1):43-55. PubMed ID: 31050803
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Safety and tolerability of repeated doses of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a systematic review and an aggregated data meta-analysis of randomized controlled trials.
Muthoka EN; Usmael K; Embaye SM; Abebe A; Mesfin T; Kazembe D; Ahmedin M; Namuganza S; Kahabuka M; Atim MG; Manyazewal T
Malar J; 2023 Oct; 22(1):320. PubMed ID: 37865784
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial.
Barsosio HC; Madanitsa M; Ondieki ED; Dodd J; Onyango ED; Otieno K; Wang D; Hill J; Mwapasa V; Phiri KS; Maleta K; Taegtmeyer M; Kariuki S; Schmiegelow C; Gutman JR; Ter Kuile FO
Lancet; 2024 Jan; 403(10424):365-378. PubMed ID: 38224710
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of intermittent preventive treatment with dihydroartemisinin-piperaquine for malaria during pregnancy: an analysis using efficacy results from Uganda and Kenya, and pooled data.
Fernandes S; Were V; Gutman J; Dorsey G; Kakuru A; Desai M; Kariuki S; Kamya MR; Ter Kuile FO; Hanson K
Lancet Glob Health; 2020 Dec; 8(12):e1512-e1523. PubMed ID: 33137287
[TBL] [Abstract][Full Text] [Related]
7. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial.
Desai M; Gutman J; L'lanziva A; Otieno K; Juma E; Kariuki S; Ouma P; Were V; Laserson K; Katana A; Williamson J; ter Kuile FO
Lancet; 2015 Dec; 386(10012):2507-19. PubMed ID: 26429700
[TBL] [Abstract][Full Text] [Related]
8. Intermittent preventive treatment for malaria in infants.
Esu EB; Oringanje C; Meremikwu MM
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD011525. PubMed ID: 34273901
[TBL] [Abstract][Full Text] [Related]
9. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
10. Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
Taylor SM; Korwa S; Wu A; Green CL; Freedman B; Clapp S; Kirui JK; O'Meara WP; Njuguna FM
PLoS Med; 2022 Oct; 19(10):e1004104. PubMed ID: 36215323
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial.
González R; Nhampossa T; Mombo-Ngoma G; Mischlinger J; Esen M; Tchouatieu AM; Mendes A; Figueroa-Romero A; Zoleko-Manego R; Lell B; Lagler H; Stoeger L; Dimessa LB; El Gaaloul M; Sanz S; Méndez S; Piqueras M; Sevene E; Ramharter M; Saúte F; Menendez C;
Lancet Infect Dis; 2024 May; 24(5):476-487. PubMed ID: 38224706
[TBL] [Abstract][Full Text] [Related]
12. Piperaquine-Induced QTc Prolongation Decreases With Repeated Monthly Dihydroartemisinin-Piperaquine Dosing in Pregnant Ugandan Women.
Hughes E; Wallender E; Kajubi R; Jagannathan P; Ochieng T; Kakuru A; Kamya MR; Clark TD; Rosenthal PJ; Dorsey G; Aweeka F; Savic RM
Clin Infect Dis; 2022 Aug; 75(3):406-415. PubMed ID: 34864925
[TBL] [Abstract][Full Text] [Related]
13. Artemisinin-based combination therapy for treating uncomplicated malaria.
Sinclair D; Zani B; Donegan S; Olliaro P; Garner P
Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007483. PubMed ID: 19588433
[TBL] [Abstract][Full Text] [Related]
14. Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.
Kajubi R; Ochieng T; Kakuru A; Jagannathan P; Nakalembe M; Ruel T; Opira B; Ochokoru H; Ategeka J; Nayebare P; Clark TD; Havlir DV; Kamya MR; Dorsey G
Lancet; 2019 Apr; 393(10179):1428-1439. PubMed ID: 30910321
[TBL] [Abstract][Full Text] [Related]
15. Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.
Kakuru A; Jagannathan P; Muhindo MK; Natureeba P; Awori P; Nakalembe M; Opira B; Olwoch P; Ategeka J; Nayebare P; Clark TD; Feeney ME; Charlebois ED; Rizzuto G; Muehlenbachs A; Havlir DV; Kamya MR; Dorsey G
N Engl J Med; 2016 Mar; 374(10):928-39. PubMed ID: 26962728
[TBL] [Abstract][Full Text] [Related]
16. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
Gogtay N; Kannan S; Thatte UM; Olliaro PL; Sinclair D
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD008492. PubMed ID: 24163021
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
[TBL] [Abstract][Full Text] [Related]
18. Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial.
Kakuru A; Jagannathan P; Kajubi R; Ochieng T; Ochokoru H; Nakalembe M; Clark TD; Ruel T; Staedke SG; Chandramohan D; Havlir DV; Kamya MR; Dorsey G
BMC Med; 2020 Aug; 18(1):207. PubMed ID: 32772921
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis.
Saito M; Mansoor R; Kennon K; Anvikar AR; Ashley EA; Chandramohan D; Cohee LM; D'Alessandro U; Genton B; Gilder ME; Juma E; Kalilani-Phiri L; Kuepfer I; Laufer MK; Lwin KM; Meshnick SR; Mosha D; Mwapasa V; Mwebaza N; Nambozi M; Ndiaye JA; Nosten F; Nyunt M; Ogutu B; Parikh S; Paw MK; Phyo AP; Pimanpanarak M; Piola P; Rijken MJ; Sriprawat K; Tagbor HK; Tarning J; Tinto H; Valéa I; Valecha N; White NJ; Wiladphaingern J; Stepniewska K; McGready R; Guérin PJ
Lancet Infect Dis; 2020 Aug; 20(8):943-952. PubMed ID: 32530424
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.
Cisse B; Cairns M; Faye E; NDiaye O; Faye B; Cames C; Cheng Y; NDiaye M; Lô AC; Simondon K; Trape JF; Faye O; NDiaye JL; Gaye O; Greenwood B; Milligan P
PLoS One; 2009 Sep; 4(9):e7164. PubMed ID: 19784374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
